| pubmed-article:17461877 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17461877 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17461877 | lifeskim:mentions | umls-concept:C0085612 | lld:lifeskim |
| pubmed-article:17461877 | lifeskim:mentions | umls-concept:C1142166 | lld:lifeskim |
| pubmed-article:17461877 | lifeskim:mentions | umls-concept:C1521970 | lld:lifeskim |
| pubmed-article:17461877 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:17461877 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
| pubmed-article:17461877 | lifeskim:mentions | umls-concept:C1555582 | lld:lifeskim |
| pubmed-article:17461877 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:17461877 | pubmed:dateCreated | 2007-4-27 | lld:pubmed |
| pubmed-article:17461877 | pubmed:abstractText | In patients with Brugada syndrome, class I antiarrhythmic drugs can trigger ventricular arrhythmias (VA). The incidence and initial characteristics of VA that developed after pilsicainide was examined in 28 patients with Brugada-type electrocardiographic (ECG) abnormalities and with a positive response in the pilsicainide test. The clinical outcome was also compared between patients with and without pilsicainide-induced VA. | lld:pubmed |
| pubmed-article:17461877 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17461877 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17461877 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17461877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17461877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17461877 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17461877 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17461877 | pubmed:month | May | lld:pubmed |
| pubmed-article:17461877 | pubmed:issn | 0147-8389 | lld:pubmed |
| pubmed-article:17461877 | pubmed:author | pubmed-author:AizawaYoshifu... | lld:pubmed |
| pubmed-article:17461877 | pubmed:author | pubmed-author:ChinushiMasao... | lld:pubmed |
| pubmed-article:17461877 | pubmed:author | pubmed-author:WashizukaTaka... | lld:pubmed |
| pubmed-article:17461877 | pubmed:author | pubmed-author:FurushimaHiro... | lld:pubmed |
| pubmed-article:17461877 | pubmed:author | pubmed-author:TanabeYasutak... | lld:pubmed |
| pubmed-article:17461877 | pubmed:author | pubmed-author:KomuraSatoruS | lld:pubmed |
| pubmed-article:17461877 | pubmed:author | pubmed-author:IzumiDaisukeD | lld:pubmed |
| pubmed-article:17461877 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17461877 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:17461877 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17461877 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17461877 | pubmed:pagination | 662-71 | lld:pubmed |
| pubmed-article:17461877 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:meshHeading | pubmed-meshheading:17461877... | lld:pubmed |
| pubmed-article:17461877 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17461877 | pubmed:articleTitle | Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome. | lld:pubmed |
| pubmed-article:17461877 | pubmed:affiliation | School of Health Science, Niigata University School of Medicine, Asahimachi Niigata, Japan. masaomi@clg.niigata-u.ac.jp | lld:pubmed |
| pubmed-article:17461877 | pubmed:publicationType | Journal Article | lld:pubmed |
